Olha Halyabar
Boston Children's Hospital
37 Papers
14 Citations
Olha Halyabar is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 17 publications. Previous affiliations of Olha Halyabar include Brigham and Women's Hospital.
Chat about Author
Papers
On the Alert for Cytokine Storm: Immunopathology in COVID-19.
Lauren A. Henderson,Scott W. Canna,Grant S. Schulert,Stefano Volpi,Pui Y. Lee,Kate F. Kernan,Roberto Caricchio,Shawn A. Mahmud,Melissa M. Hazen,Olha Halyabar,Kacie J Hoyt,Joseph Han,Alexei A. Grom,Marco Gattorno,Angelo Ravelli,Fabrizio De Benedetti,Edward M. Behrens,Randy Q. Cron,Peter A. Nigrovic +18 more
TL;DR: While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID‐19.
660
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
Pui Y. Lee,Megan Day-Lewis,Lauren A. Henderson,Kevin G. Friedman,Jeffrey Lo,Jordan E Roberts,Mindy S. Lo,Craig D. Platt,Janet Chou,Kacie J Hoyt,Annette L. Baker,Tina Banzon,Margaret H. Chang,Ezra M. Cohen,Sarah D. de Ferranti,Audrey Dionne,Saddiq Habiballah,Olha Halyabar,Jonathan S. Hausmann,Melissa M. Hazen,Erin Janssen,Esra Meidan,Ryan W. Nelson,Alan A. Nguyen,Robert P. Sundel,Fatma Dedeoglu,Peter A. Nigrovic,Jane W. Newburger,Mary Beth F. Son +28 more
TL;DR: MIS-C encompasses a broad phenotypic spectrum with clinical and laboratory features distinct from Kawasaki disease and macrophage activation syndrome and improvement was observed in all cases, including 6 cases that did not require immunomodulatory therapy.
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Sarah Ringold,Sheila T. Angeles-Han,Timothy Beukelman,Daniel J. Lovell,Carlos Cuello,Mara L. Becker,Robert A. Colbert,Brian M. Feldman,Polly J. Ferguson,Harry Gewanter,Jaime Guzman,Jennifer Horonjeff,Peter A. Nigrovic,Michael J. Ombrello,Murray H. Passo,Matthew L. Stoll,C. Egla Rabinovich,Rayfel Schneider,Olha Halyabar,Kimberly Hays,Amit Aakash Shah,Nancy Sullivan,Ann Marie Szymanski,Marat Turgunbaev,Amy S. Turner,James Reston +25 more
TL;DR: In this paper, the authors developed treatment recommendations for children with juvenile idiopathic arthritis manifesting with non-systemic polyarthritis, sacroiliitis, or enthesitis.
353
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Sheila T. Angeles-Han,Sarah Ringold,Timothy Beukelman,Daniel J. Lovell,Carlos Cuello,Mara L. Becker,Robert A. Colbert,Brian M. Feldman,Gary N. Holland,Polly J. Ferguson,Harry Gewanter,Jaime Guzman,Jennifer Horonjeff,Peter A. Nigrovic,Michael J. Ombrello,Murray H. Passo,Matthew L. Stoll,C. Egla Rabinovich,H. Nida Sen,Rayfel Schneider,Olha Halyabar,Kimberly Hays,Amit Aakash Shah,Nancy Sullivan,Ann Marie Szymanski,Marat Turgunbaev,Amy S. Turner,James Reston +27 more
TL;DR: Recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis (JIA) are developed.
CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation.
Ming Bai,Ricardo Grieshaber-Bouyer,Jun-Xia Wang,Angela B. Schmider,Zachary S. Wilson,Liling Zeng,Olha Halyabar,Olha Halyabar,Matthew D. Godin,Hung N. Nguyen,Anaïs Levescot,Pierre Cunin,Craig T. Lefort,Roy J. Soberman,Peter A. Nigrovic,Peter A. Nigrovic +15 more
TL;DR: It is concluded that CD177 signals in a β2 integrin-dependent manner to orchestrate a set of activation-mediated mechanisms that impair human neutrophil migration.
147